Bluejay Diagnostics
BJDX
3 hedge funds and large institutions have $146K invested in Bluejay Diagnostics in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
43% less capital invested
Capital invested by funds: $258K → $146K (-$112K)
50% less funds holding
Funds holding: 6 → 3 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$45K |
| 2 |
Millennium Management
New York
|
-$34K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$32K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $39K | – | – | – |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $23K | +$34K | +1 | New |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $20K | – | – | – |
|
|
4
Millennium Management
New York
| $12K | -$34K | -1 | Closed |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $12K | – | – | – |
|
6
Verition Fund Management
Greenwich,
Connecticut
| $12K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $10K | – | – | – |
|
8
Northern Trust
Chicago,
Illinois
| $9K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $9K | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$32K | -1 | Closed |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$23K | -1 | Closed |
|
|
VF
12
Virtu Financial
New York
| – | -$45K | -1 | Closed |
|
BJDX Hedge Fund Activity: Q3 2022 in Review
3 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q3 2022, worth a combined $146K — down 43% from $258K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BJDX and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $34K. The largest seller was Virtu Financial, exiting entirely with an estimated $45K sold.
- 3 institutional investors held Bluejay Diagnostics (BJDX) as of Q3 2022, down from 6 in Q2 2022.
- Funds reported $146K of Bluejay Diagnostics stock for Q3 2022, down 43% quarter-over-quarter.
- 1 fund opened new Bluejay Diagnostics positions in Q3 2022 and 4 closed out, a net change of -3 holders.
- The largest Bluejay Diagnostics buyer in Q3 2022 was Geode Capital Management, an estimated $34K added.
- The largest Bluejay Diagnostics seller in Q3 2022 was Virtu Financial, an estimated $45K sold.
Based on aggregated 13F filings for Q3 2022.